| Application no. and date | 11787633.4 (espacenet) (Federated) (European Patent Register), 20111027 | | Patent/reg. no. and date | DK/EP 2632954, 20151125 | | Publication date | 20130904 | | Priority no. and date | US 407107 P, 20101027 | | EP pub. no. and date |
EP 2632954 20130904 | | Effective date | | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | P2050DKEP | | Inventor | ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE,
NAGORSEN, Dirk, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE,
SCHEELE, Juergen, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Muenchen, DE | | Representative | KIPA AB, Drottninggatan 11
SE-252 21 Helsingborg, SE | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/46 (2006.01) | | Title | MIDLER OG FREMGANGSMÅDER TIL BEHANDLING AF DLBCL | | Int. application no. | EP2011068851 | | Int. publication no. | WO2012055961 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
